HyOrc Secures $135K via Highly Dilutive Convertible Note with Toxic Conversion Terms

summarizeSummary

HyOrc Corp entered into a Securities Purchase Agreement for a $150,000 convertible promissory note, providing $135,000 in net proceeds, but featuring a highly dilutive conversion price tied to future lowest trading prices.

check_boxKey Events

• Convertible Note Issued

  HyOrc Corp entered into a Securities Purchase Agreement for a $150,000 convertible promissory note with GS Capital Partners, LLC on March 13, 2026.

• Net Proceeds Received

  The company received net proceeds of $135,000 after an $11,000 original issue discount and approximately $4,000 in legal and transaction-related expenses.

• Highly Dilutive Conversion Terms

  The note is convertible into common stock at 77% of the lowest trading price during the ten trading days prior to conversion, posing a significant dilution risk to existing shareholders.

• Substantial Share Reserve

  The company agreed to reserve up to 5,000,000 shares of its common stock for issuance upon conversion of the note.

auto_awesomeAnalysis

This financing provides a modest capital infusion of $135,000 to HyOrc Corp, which is critical for a company of its size. However, the terms of the convertible promissory note are highly unfavorable for existing shareholders. The conversion price, set at 77% of the lowest trading price over ten days prior to conversion, creates a significant risk of substantial dilution. This "death spiral" mechanism means that as the stock price declines, more shares are required to satisfy the conversion, potentially accelerating further price drops. The company has also reserved up to 5,000,000 shares for conversion, indicating a large potential overhang on the stock. This aggressive financing suggests a pressing need for capital despite recent positive operational news. Investors should be aware of the significant dilutive pressure this agreement could exert on the stock.